New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2014
11:30 EDTCI, ESRX, CNC, MOH, WLPAnalyst sees Express Scripts benefiting from WellPoint member growth
After health insurer WellPoint (WLP) estimated that the number of people using its health insurance would rise by 1M-1.3M this year, Citigroup expects Express scripts to benefit from the increase. WHAT'S NEW: WellPoint announced that it expects its medical member base to rise by 1M-1.3M in 2014. The company also increased its 2014 earnings per share guidance to at least $8.20 per share, up from $8. In a note to investors earlier today, Citigroup analyst Garen Sarafian wrote that WellPoint had increased the outlook for its medical membership base from previous levels and that the insurer now predicts that the number of its medical members will rise by 3%-4% in 2014. Express Scripts, which provides pharmacy benefit management services for WellPoint, obtained over 12% of its 2013 revenue from WellPoint, the analyst stated. WellPoint's stronger than expected growth could lift Express Script's 2014 earnings per share by up to 7c, wrote Sarafian. He kept a $92 price target and Buy rating on Express Script. PRICE ACTION: In late morning trading, Express Scripts lost 0,4% to $77.65 and WellPoint added 0.7% to $100.45. WHAT'S NOTABLE: Other health insurers are rising in the wake of WellPoint's announcement, with Centene (CNC), Cigna (CI), and Molina (MOH) all higher by about 1%.
News For ESRX;WLP;CNC;CI;MOH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
07:19 EDTMOHLeerink to hold a tour
Subscribe for More Information
May 22, 2015
12:39 EDTCICigna May June volatility elevated
Cigna June call option implied volatility is at 29, July is at 26, October is at 27; compared to its 52 week range of 16 to 31, suggesting large near term price movement.
May 21, 2015
11:08 EDTESRXExpress Scripts management to meet with Jefferies
Meeting to be held in New York on May 26 hosted by Jefferies.
09:38 EDTESRXExpress Scripts starting to win some business, says Cleveland Research
Cleveland Research is hearing Express Scripts won the state of South Carolina business and renewal rates remain strong and on track to achieve guidance of 94%-97%.
May 20, 2015
11:51 EDTESRXExpress Scripts' Medco to pay $7.9M to resolve kickback allegations
Medco Health Solutions, a wholly-owned subsidiary of the pharmacy benefit manager Express Scripts Holding Company (ESRX), of Missouri, has agreed to pay the government $7.9M to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced. Medco provides pharmacy benefit management services to clients who receive subsidies under the Medicare Retiree Drug Subsidy program. The settlement resolves allegations that Medco solicited remuneration from AstraZeneca, a pharmaceutical manufacturer, in exchange for identifying Nexium as the “sole and exclusive” proton pump inhibitor on certain of Medco’s prescription drug lists known as formularies. The United States alleged that Medco received some or all of the remuneration from AstraZeneca in the form of reduced prices on the following AstraZeneca drugs: Prilosec, Toprol XL and Plendil. The United States contended that this kickback arrangement between Medco and AstraZeneca (AZN) violated the Federal Anti-Kickback statute, and thereby caused the submission of false or fraudulent claims for Nexium to the Retiree Drug Subsidy Program. In January 2015, the United States and AstraZeneca reached a $7.9M settlement to resolve kickback allegations arising out of the same conduct. This civil settlement resolves a lawsuit filed under the qui tam, or whistleblower, provision of the False Claims Act, which allows private citizens with knowledge of false claims to bring civil actions on behalf of the government and to share in any recovery. The lawsuit was filed by former AstraZeneca employees Paul DiMattia and F. Folger Tuggle, whose share of the settlement has not been determined. The settlement with Medco was the result of a coordinated effort among the Civil Division, the U.S. Attorney’s Office of the District of Delaware and HHS-OIG.
10:00 EDTESRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
May 19, 2015
16:41 EDTESRXExpress Scripts initiated with a Neutral at Baird
Target $94.
12:05 EDTMOHMolina Healthcare moves up following a positive Navellier mention
Subscribe for More Information
12:04 EDTCIAnthem CFO says 'good time' for 'meaningful' acquisition, Reuters reports
Subscribe for More Information
May 15, 2015
16:07 EDTMOHMolina Healthcare to acquire certain Michigan assets of HealthPlus
Subscribe for More Information
May 14, 2015
11:08 EDTESRXExpress Scripts management to meet with Maxim
Meeting to be held in St. Louis, MO on May 21 hosted by Maxim.
May 13, 2015
10:18 EDTCIAnalyst says sell Humana amid 'wishful' takeover speculation
Subscribe for More Information
06:12 EDTCIHumana downgraded to Underperform from Neutral at Sterne Agee CRT
Sterne Agee CRT analyst Brian Wright downgraded Humana (HUM) to Underperform saying speculation about a takeover is "wishful thinking" at current share levels. The stock rallied 4% yesterday after Leerink told investors that Aetna (AET) may acquire Humana or Cigna (CI) in the near-term. Wright also sees "material" risk to Humana's earnings guidance risk with paid claims outpacing premium growth. He lowered his price target for shares to $150 from $165. Humana shares closed yesterday up $6.76 to $173.38.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use